Home/Filings/4/0001225208-18-004204
4//SEC Filing

Phalen Michael P. 4

Accession 0001225208-18-004204

CIK 0000885725other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:42 PM ET

Size

13.5 KB

Accession

0001225208-18-004204

Insider Transaction Report

Form 4
Period: 2018-02-23
Phalen Michael P.
SVP & President, Endoscopy
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-23+2,452128,190 total
  • Exercise/Conversion

    Common Stock

    2018-02-24+3,440130,540 total
  • Tax Payment

    Common Stock

    2018-02-24$27.20/sh1,530$41,616129,010 total
  • Exercise/Conversion

    Deferred Stock Units

    2018-02-243,4403,441 total
    Exercise: $0.00Exp: 2019-02-24Common Stock (3,440 underlying)
  • Tax Payment

    Common Stock

    2018-02-23$27.20/sh1,090$29,648127,100 total
  • Exercise/Conversion

    Deferred Stock Units

    2018-02-232,4524,906 total
    Exp: 2020-02-23Common Stock (2,452 underlying)
Footnotes (4)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
  • [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
  • [F4]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001483882

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:42 PM ET
Size
13.5 KB